Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Amplifica
Deal Size : Undisclosed
Deal Type : Collaboration
Ingenza Collaborates with Amplifica to Advance Novel Alopecia Treatments
Details : Amplifica has partnered with Ingenza to advance the development of its signalling molecules, which stimulate dormant hair follicle stem cells and result in the active regrowth of hairs, from proof of concept through toxicology and clinical trials.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
January 20, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Amplifica
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : COVID-19 vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Ingenza Meets a Key Milestone in the Deployment of Novel Cost-Effective Covid-19 Vaccine Technology
Details : The team has efficiently produced receptor-binding domain (RBD) of the SARS-CoV-2 spike protein using engineered yeast.
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Not Applicable
August 24, 2020
Lead Product(s) : COVID-19 vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?
Reset All
